<DOC>
	<DOCNO>NCT01801176</DOCNO>
	<brief_summary>It 's monitor study . The aim ass progression free survival 3 year . Patients treated progression . Search scalability predictive factor registration treatment progression .</brief_summary>
	<brief_title>Peripheral Primitive Fibromatosis</brief_title>
	<detailed_description />
	<mesh_term>Fibroma</mesh_term>
	<criteria>Peripheral primitive fibromatosis Adults patient Peripheral primitive fibromatosis prove biopsy Peripheral primitive fibromatosis R2 resect monitoring decide MRI realize inclusion Patient information inform consent sign Local recur Head neck topography Primitive fibromatosis R0 R1 resect Specific medical treatment fibromatosis Patient already include clinical trial experimental molecule Persons deprive liberty Impossibility submit trial 's medical followup psychological , geographical social reason Previous history cancer Counter indication realization MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>prove biopsy</keyword>
</DOC>